2070-AK71 202304 Unified Agenda of Federal Regulatory and Deregulatory Actions 2070 Office of Chemical Safety and Pollution Prevention OCSPP 2000 Environmental Protection Agency EPA Cyclic Aliphatic Bromide Cluster (HBCD); Rulemaking Under the Toxic Substances Control Act (TSCA)

This proposed rulemaking will address the unreasonable risk of injury to health presented by Cyclic Aliphatic Bromide Cluster (HBCD), under its conditions of use as documented in EPA’s 2020 Risk Evaluation and 2022 revised risk determination. Section 6(a) of the Toxic Substances Control Act (TSCA) requires EPA to address by rule any unreasonable risk identified in a TSCA section 6(b) risk evaluation by applying requirements to the extent necessary so the chemical no longer presents unreasonable risk. EPA's 2020 risk evaluation for HBCD, describing the conditions of use and presenting EPA's determinations of unreasonable risk, is in docket EPA-HQ-OPPT-2019-0237, with the 2022 revised risk determination and additional materials in docket EPA-HQ-OPPT-2016-0735.

]]> Other Significant Previously Published in The Unified Agenda Proposed Rule Stage Undetermined Undetermined 40 CFR 751 15 U.S.C. 2605 Toxic Substances Control Act Statutory Final 09/15/2022 TSCA section 6(c). Statutory NPRM 09/15/2021 TSCA section 6(c). No NPRM 04/00/2024 EPA-HQ-OPPT-2020-0548. Undetermined Federal Undetermined No https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-cyclic-aliphatic-bromide-cluster-hbcd 325 Chemical Manufacturing No Yes Joshua Shodeinde 2070 Office of Chemical Safety and Pollution Prevention OCSPP 202 564-7037 shodeinde.joshua@epa.gov 1200 Pennsylvania Avenue NW, Mail Code 7408M, Washington DC 20460 Ana Corado 2070 Office of Chemical Safety and Pollution Prevention OCSPP 202 564-0140 corado.ana@epa.gov 1200 Pennsylvania Avenue NW, Mail Code 7404M, Washington DC 20460